Literature DB >> 9874001

Immunohistochemical localization of arginase II and other enzymes of arginine metabolism in rat kidney and liver.

K Miyanaka1, T Gotoh, A Nagasaki, M Takeya, M Ozaki, K Iwase, M Takiguchi, K I Iyama, K Tomita, M Mori.   

Abstract

Arginine is a precursor for the synthesis of urea, polyamines, creatine phosphate, nitric oxide and proteins. It is synthesized from ornithine by argininosuccinate synthetase and argininosuccinate lyase and is degraded by arginase, which consists of a liver-type (arginase I) and a non-hepatic type (arginase II). Recently, cDNAs for human and rat arginase II have been isolated. In this study, immunocytochemical analysis showed that human arginase II expressed in COS-7 cells was localized in the mitochondria. Arginase II mRNA was abundant in the rat small intestine and kidney. In the kidney, argininosuccinate synthetase and lyase were immunostained in the cortex, intensely in proximal tubules and much less intensely in distal tubules. In contrast, arginase II was stained intensely in the outer stripes of the outer medulla, presumably in the proximal straight tubules, and in a subpopulation of the proximal tubules in the cortex. Immunostaining of serial sections of the kidney showed that argininosuccinate synthetase and arginase II were colocalized in a subpopulation of proximal tubules in the cortex, whereas only the synthetase, but not arginase II, was present in another subpopulation of proximal tubules. In the liver, all the enzymes of the urea cycle, i.e. carbamylphosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthetase and lyase and arginase I, showed similar zonation patterns with staining more intense in periportal hepatocytes than in pericentral hepatocytes, although zonation of ornithine transcarbamylase was much less prominent. The implications of these results are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874001     DOI: 10.1023/a:1003468726969

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  15 in total

1.  Localization and differential expression of arginase II in the kidney of male and female mice.

Authors:  Olivier Levillain; Sandra Balvay; Simone Peyrol
Journal:  Pflugers Arch       Date:  2004-12-23       Impact factor: 3.657

Review 2.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

3.  An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.

Authors:  Marc Vrana; Anne Goodling; Maryam Afkarian; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2016-08-01       Impact factor: 3.922

4.  Arginase-2 mediates renal ischemia-reperfusion injury.

Authors:  Wesley M Raup-Konsavage; Ting Gao; Timothy K Cooper; Sidney M Morris; W Brian Reeves; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

5.  Interpretation of plasma amino acids in the follow-up of patients: the impact of compartmentation.

Authors:  Claude Bachmann
Journal:  J Inherit Metab Dis       Date:  2008-01-31       Impact factor: 4.982

6.  Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastomosis.

Authors:  M B Witte; N Vogt; C Stuelten; T Gotoh; M Mori; H D Becker
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

Review 7.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

8.  Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.

Authors:  Takumi Toya; Daihiko Hakuno; Yasunaga Shiraishi; Takehiko Kujiraoka; Takeshi Adachi
Journal:  Physiol Rep       Date:  2014-09-28

Review 9.  Metabolic reprogramming: A driver of cigarette smoke-induced inflammatory lung diseases.

Authors:  Linhui Li; David C Yang; Ching-Hsien Chen
Journal:  Free Radic Biol Med       Date:  2020-12-30       Impact factor: 7.376

10.  Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.

Authors:  David J Tate; Derek J Vonderhaar; Yupanqui A Caldas; Toye Metoyer; John R Patterson; Diego H Aviles; Arnold H Zea
Journal:  J Hematol Oncol       Date:  2008-09-25       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.